Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Filing


Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $22.18 per share on June 25, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On June 25, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock.
  • The sale was executed at a price of $22.18 per share.
  • Following the transaction, Boughton directly owns 171,479 shares of Hims & Hers Health, Inc.
  • The sale was conducted under a Rule 10b5-1 trading plan adopted by Boughton on September 10, 2023.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company's performance.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically views these sales in the context of the overall trading volume and the size of the sale relative to the insider's holdings.

Stakeholder Impact

  • The sale of shares by a company officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.

Key Dates

DateDescription
09/10/2023Date the Reporting Person adopted the Rule 10b5-1 trading plan
06/25/2024Date of the transaction (stock sale)

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.